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Abstract 
Curcuminoids are phenylpropanoids with high pharmaceutical potential. Herein, we 
report an engineered artificial pathway in Escherichia coli to produce natural 
curcuminoids through caffeic acid. Arabidopsis thaliana 4-coumaroyl-CoA ligase 
(4CL1) and Curcuma longa diketide-CoA synthase (DCS) and curcumin synthase 
(CURS1) were used to produce curcuminoids and 70 mg/L of curcumin was obtained 
from ferulic acid. Bisdemethoxycurcumin and demethoxycurcumin were also produced, 
but in lower concentrations, by feeding p-coumaric acid or a mixture of p-coumaric acid 
and ferulic acid, respectively. Additionally, curcuminoids were produced from tyrosine 
through the caffeic acid pathway. To produce caffeic acid, tyrosine ammonia lyase 
(TAL) from Rhodotorula glutinis and 4-coumarate 3-hydroxylase (C3H) from 
Saccharothrix espanaensis were used. Caffeoyl-CoA 3-O-methyltransferase 
(CCoAOMT) from Medicago sativa was used to convert caffeoyl-CoA to feruloyl-CoA. 
Using caffeic acid, p-coumaric acid or tyrosine as a substrate, 3.9 mg/L, 0.3 mg/L and 
0.2 mg/L of curcumin were produced, respectively. This is the first time DCS and 
CURS1 were used in vivo to produce curcuminoids and that curcumin was produced by 
feeding tyrosine. We have shown that curcumin can be produced using a pathway 
through caffeic acid. This alternative pathway represents a step forward in the 
heterologous production of curcumin using E. coli.  
  
1 Introduction 
Curcuminoids are natural phenylpropanoids from the plant Curcuma longa Linn. Its 
rhizome contains a mixture of curcuminoids, with curcumin, demethoxycurcumin and 
bisdemethoxycurcumin present in higher amounts. These compounds present in 
turmeric have long been used in traditional Asian food and medicine. Their therapeutic 
properties include anticancer, anti-inflammatory, anti-oxidant, anti-Alzeimer’s, anti-
HIV and anti-Parkinson [1-4]. Despite their numerous benefits to human health, 
curcuminoids have poor bioavailability and their natural abundance is low, thus making 
their heterologous biosynthetic production very interesting. 
Recently, curcuminoids were found to be synthesized by type III polyketide synthases 
(PKSs) and additional enzymes from the phenylpropanoid pathway in plants [5]. 
Katsuyama et al. [6] were the first to produce curcuminoids using an artificial pathway 
in E. coli. They used phenylalanine ammonia lyase (PAL) from Rhodotorula rubra with 
tyrosine ammonia lyase (TAL) activity to convert the amino acids phenylalanine and 
tyrosine directly to cinnamic acid and p-coumaric acid. 4-coumarate-CoA ligase (4CL) 
from Lithospermum erythrorhizon was used to convert cinnamic acid and p-coumaric 
acid to cinnamoyl-CoA and p-coumaroyl-CoA, respectively, and then to curcuminoids 
by curcuminoid synthase (CUS) from Oryza sativa. Acetyl-CoA carboxylase (ACC) 
from Corynebacterium glutamicum was also overexpressed to increase the intracellular 
pool of malonyl-CoA. The supplementation of amino acids to the medium led to the 
production of bisdemethoxycurcumin and other two curcuminoids, cinnamoyl-p-
coumaroylmethane and dicinnamoylmethane. The direct supplementation of carboxylic 
acids, as ferulic acid for instance, led to other curcuminoids including curcumin and 
demethoxycurcumin [6]. By adding two different unnatural carboxylic acids 
simultaneously (analogs of p-coumaric acid), Katsuyama and coworkers also produced 
unnatural curcuminoids [7]. Moreover, Wang et al. [8] produced the curcuminoid 
dicinnamoylmethane by using PALs from Trifolium pratense, 4CL1 from Arabidopsis 
thaliana and CUS from O. sativa. After CUS was discovered, Katsuyama et al. [9] 
reported that in the C. longa plant, the PKSs used to produce curcuminoids were 
diketide-CoA synthase (DCS) and curcumin synthase (CURS1). They also identified 
other CURS enzymes (CURS2 and CURS3) with different substrate specificities [10]. It 
is important to bear in mind that CUS catalyzes both steps that are catalyzed separately 
by DCS and CURS [9] (Fig. 1). 
 
In this work, we describe curcuminoids production in E. coli using an artificial pathway 
(Fig. 1). We tested 4CL1 from Arabidopsis thaliana (At4CL1) and different PKSs for 
curcuminoids production (CUS, DCS and CURS1). Curcumin, demethoxycurcumin and 
bisdemethoxycurcumin were produced by adding ferulic acid and/or p-coumaric acid as 
precursors. To produce curcuminoids, including curcumin, from the amino acid 
tyrosine, caffeic acid had to be produced as an intermediate in the pathway. TAL from 
Rhodotorula glutinis and 4-coumarate 3-hydroxylase (C3H) from S. espanaensis were 
selected to produce caffeic acid based on the results obtained in our previous work 
(manuscript submitted). Caffeoyl-CoA was converted to feruloyl-CoA by CCoAOMT 
from Medicago sativa. This alternative pathway through caffeic acid allowed, for the 
first time, the production of curcumin, the most studied curcuminoid for therapeutic 
purposes and considered in many studies as the most potent and active [3-4], from the 
amino acid tyrosine, thus representing an advance in the heterologous production of 
curcumin by E. coli. 
2 Materials and methods 
2.1 Bacterial strains, plasmids and chemicals 
E. coli NZY5α competent cells (NZYTech, Lisbon, Portugal) were used for molecular 
cloning and vector propagation and E. coli K-12 MG1655(DE3) [11] was used as the 
host for the expression of genes under T7 promoter control. The characteristics of all the 
strains and plasmids used in this study are described in Table 1. TAL, C3H, DCS, 
CURS, CUS and CCoAOMT genes were codon-optimized for E. coli, synthesized and 
cloned in the plasmid vector pUC57 by GenScript (Piscataway, NJ, USA) or NZYTech 
(Lisbon, Portugal). The DNA sequences of the codon-optimized genes are provided in 
Supplementary Material (Table S1). pAC_At4CL1 was purchased from Addgene 
(Cambridge, MA, USA). 
Restriction and ligation enzymes (NEB, Ipswich, MA, USA), KAPA HiFi DNA 
Polymerase enzyme (Kapa Biosystems, Wilmington, MA, USA), NucleoSpin® Plasmid 
Miniprep Kit (Macherey-Nagel, Düren, Germany) and DNA Clean and Concentrator 
and Gel DNA Recovery Kits (Zymo Research, Orange, CA, USA) were used according 
to the instructions provided by the manufacturers. 
L-tyrosine, p-coumaric, caffeic acid, demethoxycurcumin and bisdemethoxycurcumin 
were purchased from Sigma-Aldrich (Steinheim, Germany), ferulic acid from Acros 
(Geel, Belgium), curcumin from Fisher Scientific (Loughborough, UK), isopropyl β-D-
thiogalactopyranoside (IPTG) and Luria-Bertani (LB) medium from NZYTech (Lisbon, 
Portugal) and anhydrotetracycline (aTc) from Acros. Glucose (Acros), Na2HPO4 
(Scharlau, Sentmenat, Spain), MgSO4, KH2PO4 (Riel-deHaën, Seelze, Germany), 
NH4Cl, NaCl, CaCO3 (Panreac, Barcelona, Spain) and thiamine (Fisher Scientific, 
Loughborough, UK) were used to prepare the M9 modified salt medium. The following 
mineral traces and vitamins were supplemented to the M9 medium: FeCl3, ZnCl2, 
CoCl2, CuCl2, nicotinic acid (Riedel-deHaën), NaMoO4, H2BO3, pyridoxine, biotin, 
folic acid (Merck), riboflavin and pantothenic acid (Sigma Aldrich). Ampicillin 
(Applichem, Darmstadt, Germany), chloramphenicol, kanamycin (NZYtech) and 
spectinomycin (Panreac) were used when necessary. 
 
2.2 Construction of plasmids 
The genes encoding CUS, CURS, DCS, CCoAOMT, TAL and C3H were expressed in 
E. coli cells using the pETDuet-1, pCDFDuet-1, pRSFDuet-1 and pKVS45 vectors 
(Table 1) and were cloned using the appropriate restriction enzymes (Table S2).  
All constructed plasmids herein described were verified by colony PCR or digestion and 
confirmed by sequencing (Macrogen, Amsterdam, The Netherlands). 
 
2.3 Curcuminoids Production 
E. coli cells for gene cloning, plasmid propagation, and inoculum preparation were 
grown in LB medium at 37 ºC and 200 rpm.  
For the production of curcuminoids, the cultures were grown at 37 ºC in LB (50 mL) to 
an optical density at 600 nm of 0.3-0.4. IPTG and/or aTc were added (final 
concentration of 1 mM and 100 ng/mL, respectively) to induce protein expression. The 
culture was then incubated for 5 h at 26 ºC. Next, the cells were harvested by 
centrifugation, suspended, and incubated at 26 ºC for 63 h in modified M9 minimal salt 
medium (50 mL) containing (per liter): glucose (40 g), Na2HPO4 (6g), KH2PO4 (3g), 
NH4Cl (1g), NaCl (0.5 g), CaCl2 (17 mg), MgSO4 (58 mg), thiamine (340 mg) and 
CaCO3 (5 g) (to control the pH). Trace elements [FeCl3 (54 mg), ZnCl2 (4 mg), CoCl2 
(4 mg), NaMoO4 (4 mg), CuCl2 (2 mg) and H2BO3 (1 mg)] and vitamins [riboflavin 
(0.84 mg), folic acid (0.084 mg), nicotinic acid (12.2 mg), pyridoxine (2.8 mg), biotin 
(0.12 mg) and pantothenic acid (10.8 mg)] were also supplemented to the M9 medium. 
Depending on the plasmid(s) present in the strain, ampicillin (100 µg/mL), 
spectinomycin (100 µg/mL), chloramphenicol (30 µg/mL) and/or kanamycin (50 
µg/mL) were added. aTc and IPTG were added at the same time. Substrates were added 
at time 0 of induction in M9 medium (unless otherwise stated): tyrosine (3 mM), p-
coumaric acid (2 mM), caffeic acid (1 mM) and ferulic acid (2 mM). All the 
experiments were performed in triplicate unless otherwise specified.  
 
2.4 Curcuminoids extraction 
For posterior analysis, 2 mL of culture broth were taken at several points during the 
fermentation and adjusted to pH 3.0 with HCl (6 M). Then, the curcuminoids present in 
the samples were extracted with an equal volume of ethyl acetate. The extraction 
procedure was performed more than once for the cases in which the presence of 
curcuminoids inside the cells after the first extraction was still visible to the naked eye 
(yellow coloration). The extracts were concentrated by solvent evaporation in a fume 
hood, suspended in at least 200 µL of acetonitrile and then subjected to product analysis 
by high-performance liquid chromatography (HPLC). 
 
 
2.5 HPLC analysis of the products 
HPLC analysis was used to quantify p-coumaric acid, caffeic acid, ferulic acid, 
curcumin, demethoxycurcumin and bisdemethoxycurcumin using a system from Jasco 
(Easton, MD, USA) (PU-2080 Plus Pump unit, LG-2080-02 Ternary Gradient unit, a 
DG-2080-53 3-Line Degasser unit, a UV-2075 Plus Intelligent UV/VIS Detector unit 
and AS-2057 Plus Intelligent Sampler unit) and a Grace Alltech Platinum EPS C18 
column (3µm, 150 mm × 4.6 mm) (Grace, Columbia, MD, USA). Mobile phases A and 
B were composed of water (0.1% trifluoroacetic acid) and acetonitrile, respectively. For 
the hydroxycinnamic acids quantification, the following gradient was used at a constant 
flow rate (1 mL/min): 10 - 20% acetonitrile (mobile phase B) for 16 min. Quantification 
was based on the peak areas obtained at 310 nm for p-coumaric acid, caffeic acid and 
ferulic acid. The retention times of p-coumaric acid, caffeic acid and ferulic acid were 
8.0, 11.8 and 13.8 min, respectively. For the curcuminoids quantification, a gradient of 
40 - 43% acetonitrile (mobile phase B) for 15 min and 43% acetonitrile for an additional 
5 min was used. The curcuminoids were detected at 425 nm and the retention times of 
bisdemethoxycurcumin, demethoxycurcumin and curcumin were 12.4, 13.5 and 14.5 
min, respectively. 
 
2.6 Protein Analysis 
E. coli K-12 MG1655(DE3) cells harbouring pRSFDuet_CUS, pRSFDuet_CURS, 
pRSFDuet_DCS and pRSFDuet_CCoAOMT were grown in LB at 37 ºC to an optical 
density at 600 nm of 0.6. IPTG was added (at a final concentration of 1 mM) to induce 
protein expression, and the culture was incubated for 5 h. Samples (10 mL culture 
medium) were taken at time 0 and 5 h of induction. Samples were centrifuged and the 
cells were suspended in phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 
10 mM Na2PO4, 1.8 mM KH2PO4, pH 7.4) and disrupted by sonication on ice for 3 min. 
After centrifugation, the protein concentration from the resulting supernatant was 
determined using Protein Assay Dye Reagent Concentrate (BioRad, Hercules, CA, 
USA) and bovine gamma globulin (BSA) (NEB) as a standard. The expression levels of 
the enzymes were examined using sodium dodecyl sulfate polyacrylamide gel 
electrophoretic (SDS –PAGE) analysis. Fifteen to 20 µg of total protein were loaded in 
4-20 % Mini-PROTEAN® TGX™ Precast Gels (BioRad). The protein marker used was 
Precision Plus ProteinTM Unstained (BioRad) and/or ColorPlusTM Prestained Protein 
Ladder Broad Range (NEB). For gel staining, Bio-Safe Coomassie Stain (BioRad) was 
used.  
 
3 Results 
3.1 The 4-coumarate-CoA ligase (4CL)  
4CL enzymes convert the hydroxycinnamic acids (p-coumaric acid, caffeic acid and 
ferulic acid) to their corresponding CoA esters (p-coumaroyl-CoA, caffeoyl-CoA and 
feruloyl-CoA) (Fig. 1) with different substrate preferences and specificities. We studied 
three different 4CL enzymes (LeAt4CL1, At4CL2 and At4CL1) and only At4CL1 was 
found to be functionally expressed. Recently, this enzyme was successfully used in the 
production of curcuminoids [8] and in stilbene and flavonoid biosynthesis [12, 13]. In 
the current work, this enzyme was tested in vivo with CUS and CURS1/DCS. Since the 
results obtained regarding the production of curcuminoids were positive, all the further 
optimization tests were performed using this 4CL enzyme. 
 
3.2 Production of curcuminoids using CUS from O. sativa 
Codon-optimized CUS was cloned in pRSFDuet-1 and its expression was confirmed on 
a protein gel (44.3 kDa) (Fig. S1). After that, CUS was tested in E. coli with At4CL1 
(pRSFDuet_CUS + pAC_At4CL1) (Fig. 2). These enzymes produced 
bisdemethoxycurcumin and curcumin when p-coumaric acid and ferulic acid, 
respectively, were added to the culture medium. Curcumin was produced in higher 
amount (6.7 µM) than bisdemethoxycurcumin (0.9 µM).  
Additionally, we found that the production of curcuminoids at 24 h is lower compared 
to 63 h which is in agreement with the results reported by Katsuyama et al. [6]. This 
difference is significant (4.5 times lower) when curcumin is produced compared to 
bisdemethoxycurcumin production. Also, a yellow color of the culture medium, due to 
the increase of curcuminoids inside the cells, could only be observed after 24 h. The 
production of curcuminoids, even at low concentrations (0.9 µM) could be easily 
detected after 63 h (Fig. S2, A and B) by the observation of some cells that adhered to 
the walls of the shake flasks. 
To improve curcuminoids production, p-coumaric acid and ferulic acid were 
supplemented to the culture medium in two steps: 1 mM at time 0 of induction and 1 
mM after 24 h of induction. However, the production decreased up to around 8.6 times. 
Bisdemethoxycurcumin was also produced from tyrosine using TAL from R. glutinis 
(cloned in pCDFDuet_TAL), At4CL1 and CUS. The production was very similar to that 
obtained in the experiment in which p-coumaric acid was added in two steps, which 
probably means that the production/concentration of p-coumaric acid in the first 24 h 
affects the production of bisdemethoxycurcumin. The production of p-coumaric acid at 
63 h was around 1500 µM, thus suggesting that the TAL enzyme was highly functional. 
 
3.3 Production of curcuminoids using DCS and CURS1 from C. longa 
Codon-optimized DCS and CURS1 were cloned in pRSFDuet-1 and their protein 
expression was also confirmed on a protein gel (Fig. S1). The protein expression of 
DCS and CURS (42.9 kDa) was very high; hence in vivo production was further tested. 
Fig. 3A illustrates the curcumin production from ferulic acid using pAC_At4CL1, 
pCDFDuet_DCS and pRSFDuet_CURS1. The production with these enzymes was very 
high, 187.9 µM (70 mg/L) after 63 h. Besides, the culture medium showed a dark 
orange color (Fig. S2D), thus suggesting the production of curcuminoids.  
The addition of substrate (ferulic acid) was also tested at three different time points, 
namely 1 mM at time zero of induction in M9 medium, 0.5 mM at 5 h and an additional 
0.5 mM 24 h after induction. As previously observed (Fig. 3A), the curcuminoids 
production was also significantly lower (5.5 times) with multiple additions compared to 
adding all the ferulic acid at time zero of induction.  
To understand if the amount of cells (OD600) at the time of induction in LB influenced 
the production of curcuminoids, we induced the cultures at different OD600 values (Fig. 
3B). We found that, although the cells should be induced early, induction should not be 
too early since it can impose a metabolic burden on the host strain associated with 
protein overexpression. The addition of IPTG at an OD600 of 0.4 yielded the highest 
production titer (187.9 µM), thus suggesting that induction should be performed at an 
OD600 of 0.3-0.4. Moreover, we tested the production by inducing the cells in LB and 
then in M9 at 37 ºC instead of 26 ºC. As expected the production of curcumin at 37 ºC 
was residual. Low temperatures, around 26-30 ºC, should be used for optimal enzyme 
synthesis and curcuminoids production.  
Additionally, the effect of adding p-coumaric acid as a substrate, or a mixture of p-
coumaric acid and ferulic acid in the production of other curcuminoids was also 
evaluated (Fig. 3C). The amount of bisdemethoxycurcumin produced was very low (5.0 
µM) compared to curcumin (187.9 µM), albeit 5 times higher than that obtained when 
CUS was used instead of DCS and CURS1. The addition of both substrates enabled the 
production of bisdemethoxycurcumin, demethoxycurcumin and curcumin. Curcumin 
was produced at the highest concentration (0.6 µM), followed by demethoxycucumin, 
due to the preference of feruloy-CoA as a substrate, compared to p-coumaroyl-CoA. 
Bisdemethoxycurcumin could also be produced from tyrosine, although in very small 
amounts (Fig. 3D), i.e. almost 10 times lower than when p-coumaric acid is added. To 
improve the curcuminoids production we cloned At4CL1 in pCDFDuet-1 with DCS, 
however the curcumin production was extremely low (~ 0.1 µM) compared to that 
obtained when At4CL1 was in pAC plasmid (187.9 µM).  
 
3.4 Production of curcuminoids using caffeic acid as a precursor or intermediate 
CCoAOMT (~27.3 kDa) was successfully expressed in E. coli (Fig. S3) and was used to 
produce curcumin from caffeic acid. At4CL1 showed some specificity for caffeic acid 
and CCoAOMT was found to be functional since curcumin was produced in vivo using 
these enzymes (Fig. 4A). However, the curcumin concentration obtained was low (0.1 – 
3.9 µM) as compared with the production from ferulic acid (187.9 µM). This lower 
production is probably due to the At4CL1 specificity. The enzyme shows a much higher 
preference for ferulic acid than for p-coumaric acid and caffeic acid. However, At4CL1 
seems to have a higher preference for caffeic acid than for p-coumaric acid since the 
production of curcumin from caffeic acid and bisdemethoxycurcumin from p-coumaric 
acid (Fig. 3C) was very similar although more steps are required to obtain curcumin. 
We tested different approaches to clone CCoAOMT. CCoAOMT cloned in 
pRSFDuet_CURS1 leads to a significant production of curcuminoids, while if cloned in 
pCDFDuet_DCS the production is residual. Consequently, the first approach was 
chosen to attempt the production of curcuminoids from tyrosine. 
Curcuminoids production, including curcumin, was obtained from p-coumaric acid and 
tyrosine by using caffeic acid as an intermediate (Fig. 4B and C). When p-coumaric is 
used as a precursor, the production of curcuminoids is higher than when using tyrosine. 
Indeed, this was expected since, as the number of intermediates increases, the 
production of curcuminoids decreases, due to the loss of product in each step of the 
pathway. When p-coumaric acid is used as a substrate, bisdemethoxycurcumin is the 
curcuminoid produced in higher concentrations (~0.5 µM), followed by 
demethoxycurcumin. This occurs probably because, due to the high concentration of p-
coumaric acid added, p-coumaroyl-CoA is present in a higher concentration than 
feruloyl-CoA, thus being more available to produce a higher concentration of 
bisdemethoxycurcumin and demethoxycurcumin. Also, pKVS45_C3H enabled a higher 
concentration of caffeic acid than pETDuet_C3H (Fig. 4C), as we have observed 
previously (manuscript submitted). Consequently, a higher caffeic acid concentration 
(299.5 µM) allowed the production of more curcumin (0.3 µM). When tyrosine is used 
as substrate, the caffeic acid concentration obtained is lower (79.9 - 174.4 µM), and the 
p-coumaric acid concentration produced is also lower (354.6 – 568.0 µM) than that 
maintained when it is added as a precursor (1392.6 – 1571.3 µM). Although p-coumaric 
is present in a higher concentration than caffeic acid (Fig.4C, (5) and (6)), At4CL1 
seems to prefer caffeic acid over p-coumaric acid and consequently, curcumin (0.1 – 0.2 
µM) is produced in higher amounts than bisdemethoxycurcumin (0.03 – 0.07 µM). The 
concentration of the asymmetric curcuminoid (demethoxycurcumin) is higher than the 
concentration obtained of the symmetric curcuminoids (curcumin and 
bisdemethoxycurcumin). The system using TAL and C3H in the same plasmid 
(pETDuet_TAL_C3H) works better than cloning TAL in pCDFDuet_DCS. In the latter 
case, low expression levels of TAL seems to be the cause, as was found for CCoAOMT 
(Fig. 4A), since the p-coumaric acid production was low (354.6 µM) and consequently 
the caffeic acid production was also low (79.9 µM), thus leading to a lower production 
of curcuminoids. 
 
4 Discussion 
Since there is an increasing interest in curcumin and other curcuminoids due to their 
several recognized beneficial effects, synthetic biology and metabolic engineering 
constitute good approaches to improve their availability. The discovery of CUS from O. 
sativa allowed the production of curcuminoids in E. coli [6, 7] and in vitro [14], which 
represented an important step forward in the production of curcuminoids using the 
above mentioned strategies. CUS has the advantage of catalyzing the three steps that are 
catalyzed by different PKSs (CURS and DCS) in C. longa: (a) condensation of 
malonyl-CoA with feruloyl-CoA (or other CoA ester) to produce diketide-CoA; (b) 
hydrolysis of diketide-CoA to its corresponding β-keto acid; and (c) decarboxylative 
condensation of the β-keto acid to the second molecule of feruloyl-CoA (Fig. 1). This 
enzyme would make the production of curcuminoids from tyrosine simpler by 
decreasing the number of enzymes needed for the pathway to function. In this study, we 
used CUS to produce the three main curcuminoids in C. longa: bisdemethoxycurcumin, 
demethoxycurcumin and curcumin. However, the amount of curcuminoids produced 
with CUS was lower than the expected. The low titers (0.9 µM of 
bisdemethoxycurcumin and 6.7 µM of curcumin) may be due to use of plant enzymes in 
the pathway, which usually are poorly stable in prokaryotes even with codon-
optimization owing to the lack of specific protein folding chaperones and post-
translational modifications. Ferulic acid and/or feruloyl-CoA seem to be the preferred 
substrates since curcumin was produced in higher amount than bisdemethoxycurcumin. 
However, At4CL1 was reported to prefer p-coumaric acid to ferulic acid [15] and 
Katsuyama et al. [14] also concluded by in vitro experiments that CUS prefers p-
coumaroyl-CoA as a substrate. Therefore, the reason behind the higher curcumin 
production in this study is not clear. However, in vivo experiments by the same authors 
[6] revealed that the CUS enzyme together with Le4CL produces very similar amounts 
of bisdemethoxycurcumin and curcumin from p-coumaric acid and ferulic acid, 
respectively, although the curcumin concentration obtained was slightly higher. It 
cannot be concluded if the higher concentration of curcumin obtained in vivo was due to 
Le4CL substrate specificity, since it is unknown.  
DCS and CURS1 were also chosen to test the curcuminoids production due to the 
promising results previously reported in vitro [9, 10, 16]. Although these two genes 
were successfully expressed in E. coli and the enzymes were used to produce several 
curcuminoids, including curcumin, DCS and CURS1 were never tested in vivo. CURS1 
was named curcumin synthase due to its pronounced preference for feruloyl-CoA [9]. 
Moreover, other CURS were identified. CURS2 was also reported to prefer feruloyl-
CoA and CURS3 favored both feruloy-CoA and p-coumaroyl-CoA [10]. Since 
curcumin has been reported to possess, in some systems, a higher therapeutic value than 
the other curcuminoids [17], CURS1 was chosen as it has the highest turnover rate 
towards feruloyl-CoA, as well as the highest difference between the catalytic efficiency 
towards feruloyl-CoA and p-coumaroyl-CoA [10]. The production of curcumin using 
CURS1 and DCS was surprisingly higher than we expected (187.9 µM), especially 
taking into account the results obtained with CUS. This is the first report that 
demonstrates that these two enzymes can be used efficiently to produce curcuminoids in 
E. coli and provide high production titers. A higher concentration (113 mg/L) was 
reported using Le4CL, CUS and ACC [6]. It is important to note that ACC can be very 
important to obtain high curcuminoids titers, in particular if there is a limitation of 
malonyl-CoA in the cells. However, comparing the results from Katsuyama et al. [6] 
and Wang et al. [8] we can conclude that a high production of curcuminoids can also be 
obtained without ACC overexpression. Katsuyama et al. [6] when using R. rubra PAL, 
Le4CL, CUS and ACC, and adding phenylalanine or cinnamic acid were able to obtain 
around 107 mg/L or 84 mg/L of dicinnamoylmethane, respectively; while Wang et al. 
[8] by using T. pratense PAL, At4CL1 and CUS, and adding phenylalanine obtained 
360 mg/L of dicinnamoylmethane – i.e. a dicinnamoylmethane concentration 3.4 times 
higher without the need of using overexpressed ACC to increase the malonyl-CoA pool 
in E. coli. Even though Wang et al. [8] obtained high production of 
dicinnamoylmethane and we were able to achieve a high production of curcumin, the 
ACC requirements should be further evaluated to confirm if malonyl-CoA is limiting 
the production of curcuminoids.  
To improve curcuminoids production, the substrates were supplemented to the culture 
medium in two steps. This stepwise approach was tested due to the possible toxicity of 
p-coumaric and ferulic acids to the cells [12, 18-22], and because we found that this 
strategy improved the production of caffeic acid in our previous work (manuscript 
submitted). However, in the current study the two-step feeding was shown to be 
counterproductive, i.e. the production decreased which means that the slow process of 
curcuminoids production requires all the substrate available at the beginning of the 
fermentation to achieve a high production. 
The previous report on the heterologous production of curcumin involves the direct 
supplementation of ferulic acid in the culture medium [6]. To our knowledge, this is the 
first report on the production of curcumin from tyrosine through the production of 
caffeic acid as an intermediate. CCoAOMT from M. sativa was used to catalyze the 
methylation of caffeoyl-CoA, its preferred substrate, to feruloyl-CoA and it was chosen 
since it has already been expressed in E. coli [23]. After At4CL1 converts caffeic acid to 
caffeoyl-CoA, CCoAOMT converts caffeoyl-CoA to feruloyl-CoA which DCS and 
CURS1 can convert to curcumin. To date, the levels of production are not very high; 
however these can be improved by balancing different expression levels. Imbalances 
can lead to over- or underproduction of enzymes and accumulation of intermediate 
metabolites which may result in suboptimal titers. CURS1 has a higher preference for 
feruloyl-CoA than for p-coumaroyl-CoA. However, the DCS preference for p-coumaric 
acid or ferulic acid is unknown, although it is established that its affinity for malonyl-
CoA is high [9]. At4CL1 was reported to have a high affinity for p-coumaric acid, 
followed by caffeic acid and a very low specificity for ferulic acid [15], which seems to 
be contradicted by our results. All these issues make it difficult to control the 
curcuminoids production ratios, and more information about the catalytic properties of 
all the enzymes involved in the curcuminoids biosynthetic pathway is required. 
Although up to now the production of curcuminoids from tyrosine is low (up to 0.6 µM) 
and the curcuminoids ratio difficult to control, this alternative pathway successfully led 
to the production of curcumin from tyrosine. Curcumin, the most studied curcuminoid 
for therapeutic purposes and in many studies considered as the most potent and active 
[3-4], was only shown to be produced in E. coli using ferulic acid. This represents a 
disadvantage when the production cost of curcumin is relevant, but also for the cases in 
which curcumin is used as a drug that needs to be produced and delivered in situ. By 
producing curcumin using tyrosine (endogenous amino acid) and using (in the future) a 
tyrosine overproducing strain, the need to add expensive precursors disappears and the 
production process is also simplified. Although it is clear that the pathway herein 
described, depending on the application, has to be further refined and optimized this is 
the first step towards the production of curcumin from an amino acid in E. coli and it is 
also the first time that caffeic acid is used as an intermediate to produce curcuminoids. 
Therefore, this alternative pathway represents a significant progress in the heterologous 
production of curcumin using E. coli.  
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Table 1. Bacterial strains and plasmids used in this study 
Strains Relevant Genotype Source 
E. coli NZY5α 
fhuA2∆(argF-lacZ)U169 phoA glnV44 Φ80 
∆(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
NZYTech 
E. coli K-12 MG1655 DE3 F- λ-  ilvG- rfb-50 rph-1 λ(DE3) [11] 
Plasmids Construct Source 
pETDuet-1 ColE1(pBR322) ori, lacI, double T7lac, AmpR Novagen 
pCDFDuet-1 CloDF13 ori, lacI, double T7lac, StrepR Novagen 
pRSFDuet-1 RSF ori, lacI, double T7lac, KanR Novagen 
pKVS45 p15A ori, tetR, Ptet, AmpR [24] 
pUC57_CCoAOMT pUC57 carrying codon-optimized CCoAOMT from M. sativa  GenScript 
pUC57_CUS pUC57 carrying codon-optimized CUS from O. 
sativa NZYTech 
pUC57_DCS pUC57 carrying codon-optimized DCS from C. longa NZYTech 
pUC57_CURS1 pUC57 carrying codon-optimized CURS1 from C. longa NZYTech 
pAC_At4CL1 pAC carrying not codon-optimized 4CL1 from A. thaliana Addgene (35947) 
pETDuet_TAL pETduet-1 carrying codon-optimized TAL from R. glutinis unpublished data 
pETDuet_C3H pETduet-1 carrying codon-optimized C3H from S. espanaensis unpublished data 
pETDuet_TAL_C3H pETduet-1 carrying codon-optimized TAL from R. glutinis and C3H from S. espanaensis unpublished data 
pKVS45_C3H pKVS45 carrying codon-optimized C3H from S. espanaensis unpublished data 
pCDFDuet_TAL pCDFDuet-1 carrying codon-optimized TAL from R. glutinis unpublished data 
pRSFDuet_CUS pRSFDuet-1 carrying codon-optimized CUS from O. sativa this study 
pRSFDuet_CURS1 pRSFDuet-1 carrying codon-optimized CURS1 from C. longa this study 
pCDFDuet_DCS pCDFDuet-1 carrying codon-optimized DCS from C. longa this study 
pRSFDuet_CCoAOMT pRSFDuet-1 carrying codon-optimized CCoAOMT from M. sativa this study 
pRSFDuet_At4CL1_CUS pRSFDuet_At4CL1 carrying codon-optimized CUS from O. sativa this study 
pCDFDuet_DCS_CCoAOMT pCDFDuet_DCS carrying codon-optimized CCoAOMT from M. sativa this study 
pRSFDuet_CURS1_CCoAOMT pRSFDuet_CURS carrying codon-optimized this study 
CCoAOMT from M. sativa 
pCDFDuet_DCS_TAL pCDFDuet_DCS carrying codon-optimized TAL from R. glutinis this study 
pCDFDuet_DCS_At4CL1 pCDFDuet_DCS carrying 4CL1 from A. 
thaliana this study 
 
 
Figure Legends: 
Figure 1. Proposed curcuminoids biosynthetic pathway in E. coli and the reactions 
catalyzed by the enzymes in this study. TAL: tyrosine ammonia lyase; C3H: 4-
coumarate 3-hydroxylase; 4CL: 4-coumarate-CoA ligase; CCoAOMT: caffeoyl-CoA 3-
O-methyltransferase; DCS: diketide-CoA synthase; CURS1: curcumin synthase; CUS: 
curcuminoid synthase. 
Figure 2. Curcuminoids production from p-coumaric acid and ferulic acid using 4-
coumarate-CoA ligase (4CL1) from Arabidopsis thaliana and curcuminoid synthase 
(CUS) from Oryza sativa. Bisdemethoxycurcumin was also produced from tyrosine 
using tyrosine ammonia lyase (TAL) from Rhodotorula glutinis. Error bars are standard 
deviations from triplicate experiments. 
Figure 3. Curcuminoids production using 4-coumarate-CoA ligase (4CL1) from 
Arabidopsis thaliana and diketide-CoA synthase (DCS) and curcumin synthase 1 
(CURS1) from Curcuma longa. Curcumin production from ferulic acid (A). Effect of 
IPTG induction at different OD600 values and effect of induction temperature on the 
production titers of curcumin using ferulic acid as substrate (B). Curcuminoids 
production from p-coumaric acid and a mixture of p-coumaric acid and ferulic acid (C). 
Bisdemethoxycurcumin production from tyrosine using tyrosine ammonia lyase (TAL) 
from Rhodotorula glutinis and curcumin production from ferulic acid using a different 
plasmid configuration (D). Error bars are standard deviations from triplicate 
experiments. 
Figure 4. Curcumin production from caffeic acid using caffeoyl-CoA 3-O-
methyltransferase (CCoAOMT) from Medicago sativa, 4-coumarate-CoA ligase (4CL1) 
from Arabidopsis thaliana and diketide-CoA synthase (DCS) and curcumin synthase 1 
(CURS1) from Curcuma longa (A). Curcuminoid production from p-coumaric acid and 
tyrosine using caffeic acid as an intermediate and using tyrosine ammonia lyase (TAL) 
from Rhodotorula glutinis, 4-coumarate 3-hydroxylase (C3H) from Saccharothrix 
espanaensis, CCoAOMT 4CL1, DCS and CURS1. In (B) bisdemethoxycurcumin, 
demethoxycurcumin and curcumin production are shown while in (C) p-coumaric acid 
and caffeic acid are reported. Error bars are standard deviations from triplicate 
experiments. 
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Table S1. Gene sequences of TAL, C3H, CCoAOMT, CUS, DCS and CURS1 with codon optimization 
Gene Sequence 
TAL 
(Rhodotorula 
glutinis) 
ATGGCTCCGCGTCCGACCTCGCAATCCCAAGCTCGCACCTGCCCGACCACCCAAGTTACCCAAGTTGACATCGTTGAAAAAATGCTG
GCGGCGCCGACCGATTCGACGCTGGAACTGGACGGCTATAGCCTGAACCTGGGTGATGTGGTTTCTGCAGCACGTAAAGGTCGTCCG
GTGCGTGTTAAAGATTCAGACGAAATTCGCTCGAAAATCGATAAAAGCGTGGAATTTCTGCGTAGCCAGCTGAGCATGTCTGTTTAC
GGCGTCACCACGGGTTTCGGCGGTTCAGCCGATACCCGCACGGAAGACGCCATTTCGCTGCAGAAAGCACTGCTGGAACATCAACTG
TGCGGCGTGCTGCCGAGCTCTTTTGATAGCTTCCGCCTGGGCCGTGGTCTGGAAAACTCTCTGCCGCTGGAAGTCGTGCGTGGTGCAA
TGACCATCCGTGTTAATTCCCTGACGCGCGGTCATTCAGCTGTCCGTCTGGTTGTCCTGGAAGCGCTGACCAACTTTCTGAATCACGG
TATTACGCCGATCGTGCCGCTGCGTGGTACCATTAGTGCATCCGGTGATCTGAGCCCGCTGTCTTATATTGCAGCTGCGATCTCTGGC
CACCCGGACAGTAAAGTTCATGTGGTTCACGAGGGTAAAGAAAAAATCCTGTACGCCCGTGAAGCTATGGCGCTGTTCAACCTGGAA
CCGGTCGTGCTGGGCCCGAAAGAAGGCCTGGGTCTGGTGAATGGTACGGCTGTTTCAGCGTCGATGGCCACCCTGGCACTGCATGAT
GCCCACATGCTGAGCCTGCTGAGCCAGTCTCTGACCGCGATGACGGTCGAAGCGATGGTGGGCCATGCAGGTAGCTTTCATCCGTTC
CTGCACGATGTGACCCGTCCGCACCCGACGCAGATTGAAGTTGCAGGCAACATCCGCAAACTGCTGGAAGGTAGCCGTTTTGCGGTG
CATCACGAAGAAGAAGTGAAAGTGAAAGATGACGAAGGCATTCTGCGCCAGGATCGTTATCCGCTGCGTACCAGTCCGCAATGGCT
GGGTCCGCTGGTCTCCGACCTGATTCATGCCCACGCAGTGCTGACCATCGAAGCGGGTCAGAGTACCACGGATAACCCGCTGATTGA
CGTGGAAAATAAAACCTCTCATCACGGCGGTAACTTTCAAGCCGCAGCTGTTGCCAATACGATGGAAAAAACGCGCCTGGGCCTGGC
ACAGATCGGTAAACTGAATTTCACCCAACTGACGGAAATGCTGAACGCAGGCATGAATCGTGGTCTGCCGAGCTGCCTGGCAGCAGA
AGATCCGAGTCTGTCCTATCATTGTAAAGGCCTGGACATTGCAGCTGCGGCCTACACCTCTGAACTGGGTCATCTGGCGAACCCGGTT
ACCACGCACGTCCAGCCGGCTGAAATGGCGAACCAAGCCGTGAATTCCCTGGCACTGATCTCAGCTCGTCGCACCACGGAATCGAAT
GATGTCCTGAGCCTGCTGCTGGCGACCCATCTGTATTGTGTTCTGCAGGCTATTGACCTGCGCGCGATCGAATTTGAATTCAAAAAAC
AGTTTGGCCCGGCTATTGTGAGCCTGATCGATCAACACTTCGGCTCTGCCATGACCGGTAGTAACCTGCGTGACGAACTGGTGGAAA
AAGTTAATAAAACGCTGGCCAAACGCCTGGAACAGACCAACAGTTACGATCTGGTGCCGCGTTGGCATGACGCATTTTCCTTCGCAG
CTGGTACGGTTGTCGAAGTTCTGAGTTCCACCTCACTGTCGCTGGCGGCCGTCAATGCCTGGAAAGTGGCAGCTGCGGAAAGTGCAA
TTTCCCTGACCCGCCAAGTGCGTGAAACGTTTTGGTCAGCAGCATCGACGTCATCGCCGGCACTGAGCTATCTGTCTCCGCGCACCCA
AATTCTGTACGCTTTTGTTCGTGAAGAACTGGGCGTCAAAGCGCGTCGCGGCGATGTTTTCCTGGGTAAACAGGAAGTGACCATCGG
TAGTAATGTTTCCAAAATCTATGAAGCTATCAAAAGCGGTCGTATCAATAATGTGCTGCTGAAAATGCTGGCATAA 
C3H 
(Saccharothrix 
espanaensis) 
ATGACGATTACCTCTCCGGCACCGGCTGGTCGCCTGAACAATGTCCGCCCGATGACGGGTGAAGAATACCTGGAATCCCTGCGTGAC
GGCCGTGAAGTGTATATTTACGGTGAACGCGTCGATGACGTGACCACGCATCTGGCGTTCCGCAACAGCGTTCGTTCTATCGCCCGCC
TGTATGATGTCCTGCACGACCCGGCATCCGAAGGTGTTCTGCGTGTCCCGACCGATACGGGTAATGGTGGTTTTACCCATCCGTTTTT
CAAAACGGCGCGTAGCTCTGAAGACCTGGTGGCGGCCCGTGAAGCCATTGTCGGCTGGCAACGCCTGGTGTATGGCTGGATGGGTCG
TACCCCGGATTACAAAGCAGCGTTTTTCGGTACGCTGGACGCTAACGCGGAATTTTATGGCCCGTTCGAAGCCAATGCACGTCGCTG
GTATCGTGATGCACAGGAACGCGTTCTGTACTTCAACCATGCTATCGTTCACCCGCCGGTCGATCGTGACCGTCCGGCTGATCGTACC
GCAGACATTTGCGTCCATGTGGAAGAAGAAACGGATTCAGGCCTGATCGTGTCGGGTGCCAAAGTGGTTGCAACCGGTTCTGCTATG
ACGAACGCGAATCTGATTGCCCACTATGGTCTGCCGGTTCGCGATAAAAAATTTGGCCTGGTGTTCACCGTTCCGATGAACAGTCCGG
GTCTGAAACTGATCTGTCGTACCTCCTATGAACTGATGGTGGCCACGCAGGGCTCACCGTTTGATTACCCGCTGAGTTCCCGCCTGGA
TGAAAATGACAGCATTATGATCTTTGATCGTGTTCTGGTCCCGTGGGAAAACGTTTTCATGTACGACGCAGGCGCGGCCAATAGCTTT
GCTACCGGCTCTGGTTTCCTGGAACGCTTTACCTTCCATGGTTGCACGCGTCTGGCAGTGAAACTGGATTTTATTGCAGGCTGTGTTAT
GAAAGCTGTGGAAGTTACCGGCACCACGCACTTCCGCGGTGTTCAGGCGCAAGTCGGCGAAGTGCTGAACTGGCGTGATGTCTTTTG
GGGTCTGTCGGACGCTATGGCGAAAAGTCCGAATTCCTGGGTGGGCGGTAGCGTTCAGCCGAACCTGAATTATGGCCTGGCCTACCG
CACCTTTATGGGCGTGGGTTATCCGCGTATTAAAGAAATTATCCAGCAAACGCTGGGCTCTGGTCTGATCTACCTGAACTCATCGGCA
GCTGATTGGAAAAATCCGGACGTTCGCCCGTATCTGGATCGTTACCTGCGCGGCAGTCGTGGTATTCAGGCAATCGATCGTGTCAAA
CTGCTGAAACTGCTGTGGGACGCAGTGGGTACCGAATTCGCAGGTCGTCATGAACTGTATGAACGCAACTACGGCGGTGATCACGAA
GGTATTCGTGTGCAGACCCTGCAAGCCTATCAGGCAAATGGTCAAGCGGCCGCACTGAAAGGCTTTGCGGAACAGTGTATGTCGGAA
TATGACCTGGATGGCTGGACCCGCCCGGACCTGATTAACCCGGGCACGTAA 
CCoAOMT 
(Medicago 
sativa) 
ATGGCTACGAATGAAGACCAGAAACAGACGGAATCAGGCCGCCACCAAGAAGTCGGTCACAAATCACTGCTGCAATCAGATGCGCT
GTATCAGTACATTCTGGAAACGAGCGTCTTTCCGCGTGAACATGAAGCTATGAAAGAACTGCGCGAAGTGACCGCGAAACACCCGTG
GAACATCATGACCACGAGCGCTGATGAAGGCCAATTCCTGTCTATGCTGCTGAAACTGATTAACGCGAAAAATACCATGGAAATCGG
CGTGTATACGGGTTACAGCCTGCTGGCAACCGCACTGGCAATTCCGGAAGACGGTAAAATTCTGGCCATGGATATCAACAAAGAAAA
CTACGAACTGGGCCTGCCGGTTATCAAAAAAGCCGGTGTCGACCATAAAATCGATTTTCGTGAAGGCCCGGCACTGCCGGTTCTGGA
CGAAATGATCAAAGATGAGAAAAACCATGGTAGTTACGATTTCATCTTCGTCGATGCGGACAAAGATAACTATCTGAATTACCACAA
ACGCCTGATTGACCTGGTCAAAGTGGGCGGTGTGATCGGCTATGATAACACGCTGTGGAATGGTTCCGTGGTTGCACCGCCGGACGC
ACCGCTGCGTAAATACGTGCGTTATTACCGCGATTTCGTTCTGGAACTGAATAAAGCTCTGGCGGTTGATCCGCGCATTGAAATCTGT
ATGCTGCCGGTGGGTGACGGTATTACCATCTGTCGTCGTATTAAATGA 
CUS 
(Oryza sativa) 
ATGGCTCCGACCACGACGATGGGTTCCGCTCTGTATCCGCTGGGTGAAATGCGCCGTAGTCAACGCGCCGATGGCCTGGCAGCAGTC
CTGGCCATTGGCACCGCAAACCCGCCGAATTGCGTTACGCAGGAAGAAATCCCGGATTTTTATTTCCGCGTCACCAACAGCGACCAT
CTGACGGCCCTGAAAGACAAGTTCAAACGTATTTGTCAGGAAATGGGTGTGCAACGTCGCTACCTGCATCACACCGAAGAAATGCTG
AGCGCGCACCCGGAATTTGTCGATCGTGACGCCCCGTCTCTGGATGCACGTCTGGACATTGCCGCGGATGCCGTTCCGGAACTGGCA
GCTGAAGCGGCCAAAAAGGCCATTGCAGAATGGGGCCGTCCGGCAGCTGATATCACCCATCTGGTGGTTACCACGAATAGTGGCGC
GCACGTGCCGGGTGTTGATTTTCGCCTGGTGCCGCTGCTGGGTCTGCGCCCGTCCGTTCGTCGCACGATGCTGCATCTGAATGGTTGC
TTTGCGGGTTGTGCCGCCCTGCGTCTGGCTAAAGATCTGGCGGAAAATTCTCGTGGCGCACGCGTGCTGGTCGTGGCAGCTGAACTG
ACCCTGATGTATTTTACGGGCCCGGATGAAGGTTGCTTCCGCACCCTGCTGGTGCAGGGTCTGTTTGGTGATGGTGCGGCGGCAGTTA
TTGTCGGTGCTGATGCGGATGACGTTGAACGTCCGCTGTTCGAAATCGTCTCAGCTGCGCAGACCATTATCCCGGAATCGGACCATGC
ACTGAACATGCGTTTTACGGAACGTCGCCTGGATGGTGTCCTGGGTCGCCAAGTGCCGGGTCTGATTGGTGACAACGTGGAACGTTG
TCTGCTGGATATGTTTGGTCCGCTGCTGGGCGGTGACGGCGGTGGCGGTTGGAATGACCTGTTTTGGGCGGTCCACCCGGGTAGCTCT
ACCATTATGGATCAGGTGGATGCGGCACTGGGCCTGGAACCGGGCAAGCTGGCTGCGAGTCGTCGCGTGCTGTCCGACTACGGCAAT
ATGAGCGGTGCTACGGTTATCTTTGCGCTGGATGAACTGCGTCGCCAACGCAAAGAAGCCGCAGCTGCGGGTGAATGGCCGGAACTG
GGTGTTATGATGGCCTTTGGTCCGGGTATGACGGTTGATGCGATGCTGCTGCACGCCACGAGCCATGTGAACTAA 
DCS 
(Curcuma longa) 
ATGGAAGCTAACGGTTACCGTATCACCCACTCTGCTGACGGTCCAGCTACCATCCTGGCTATCGGTACCGCTAACCCGACCAACGTTG
TTGACCAGAACGCTTACCCGGACTTCTACTTCCGTGTTACCAACTCTGAATACCTGCAGGAACTGAAAGCTAAATTCCGTCGTATCTG
CGAAAAAGCTGCTATCCGTAAACGTCACCTGTACCTGACCGAAGAAATCCTGCGTGAAAACCCGTCTCTGCTGGCTCCGATGGCTCC
GTCTTTCGACGCTCGTCAGGCTATCGTTGTTGAAGCTGTTCCGAAACTGGCTAAAGAAGCTGCTGAAAAAGCTATCAAAGAATGGGG
TCGTCCGAAATCTGACATCACCCACCTGGTTTTCTGCTCTGCTTCTGGTATCGACATGCCGGGTTCTGACCTGCAGCTGCTGAAACTGC
TGGGTCTGCCGCCGTCTGTTAACCGTGTTATGCTGTACAACGTTGGTTGCCACGCTGGTGGTACCGCTCTGCGTGTTGCTAAAGACCT
GGCTGAAAACAACCGTGGTGCTCGTGTTCTGGCTGTTTGCTCTGAAGTTACCGTTCTGTCTTACCGTGGTCCGCACCCGGCTCACATC
GAATCTCTGTTCGTTCAGGCTCTGTTCGGTGACGGTGCTGCTGCTCTGGTTGTTGGTTCTGACCCGGTTGACGGTGTTGAACGTCCGAT
CTTCGAAATCGCTTCTGCTTCTCAGGTTATGCTGCCGGAATCTGCTGAAGCTGTTGGTGGTCACCTGCGTGAAATCGGTCTGACCTTCC
ACCTGAAATCTCAGCTGCCGTCTATCATCGCTTCTAACATCGAACAGTCTCTGACCACCGCTTGCTCTCCGCTGGGTCTGTCTGACTGG
AACCAGCTGTTCTGGGCTGTTCACCCGGGTGGTCGTGCTATCCTGGACCAGGTTGAAGCTCGTCTGGGTCTGGAAAAAGACCGTCTG
GCTGCTACCCGTCACGTTCTGTCTGAATACGGTAACATGCAGTCTGCTACCGTTCTGTTCATCCTGGACGAAATGCGTAACCGTTCTG
CTGCTGAAGGTCACGCTACCACCGGCGAAGGTCTGGACTGGGGTGTTCTGCTGGGTTTCGGTCCAGGTCTGTCTATCGAAACCGTTGT
TCTGCACTCTTGCCGTCTGAACTAA 
CURS1 
(Curcuma longa) 
ATGGCTAACCTGCACGCTCTGCGTCGTGAACAGCGTGCTCAGGGTCCGGCTACCATCATGGCTATCGGTACCGCTACCCCGCCGAAC
CTGTACGAACAGTCTACCTTCCCGGACTTCTACTTCCGTGTTACCAACTCTGACGACAAACAGGAACTGAAAAAAAAATTCCGTCGTA
TGTGCGAAAAAACCATGGTTAAAAAACGTTACCTGCACCTGACCGAAGAAATCCTGAAAGAACGTCCGAAACTGTGCTCTTACAAAG
AAGCTTCTTTCGACGACCGTCAGGACATCGTTGTTGAAGAAATCCCGCGTCTGGCTAAAGAAGCTGCTGAAAAAGCTATCAAAGAAT
GGGGTCGTCCGAAATCTGAAATCACCCACCTGGTTTTCTGCTCTATCTCTGGTATCGACATGCCGGGTGCTGACTACCGTCTGGCTAC
CCTGCTGGGTCTGCCGCTGACCGTTAACCGTCTGATGATCTACTCTCAGGCTTGCCACATGGGTGCTGCTATGCTGCGTATCGCTAAA
GACCTGGCTGAAAACAACCGTGGTGCTCGTGTTCTGGTTGTTGCTTGCGAAATCACCGTTCTGTCTTTCCGTGGTCCGAACGAAGGTG
ACTTCGAAGCTCTGGCTGGTCAGGCTGGTTTCGGTGACGGTGCTGGTGCTGTTGTTGTTGGTGCTGACCCGCTGGAAGGTATCGAAAA
ACCGATCTACGAAATCGCTGCTGCTATGCAGGAAACCGTTGCTGAATCTCAGGGTGCTGTTGGTGGTCACCTGCGTGCTTTCGGTTGG
ACCTTCTACTTCCTGAACCAGCTGCCGGCTATCATCGCTGACAACCTGGGTCGTTCTCTGGAACGTGCTCTGGCTCCGCTGGGTGTTC
GTGAATGGAACGACGTTTTCTGGGTTGCTCACCCGGGTAACTGGGCTATCATCGACGCTATCGAAGCTAAACTGCAGCTGTCTCCGG
ACAAACTGTCTACCGCTCGTCACGTTTTCACCGAATACGGTAACATGCAGTCGGCGACCGTCTACTTCGTGATGGACGAACTGCGTAA
ACGTTCTGCTGTTGAAGGTCGTTCTACCACCGGCGACGGTCTGCAGTGGGGTGTTCTGCTGGGTTTCGGTCCAGGTCTGTCTATCGAA
ACCGTTGTTCTGCGTTCTATGCCGCTGTAA 
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Table S2. Set of primers for PCR amplification (forward (FW) and reverse (REV) primers) 1 
Primer name Primer sequence[a] Restriction 
enzyme site 
CUS_FW GGATCCCATGGCTCCGACCACG BamHI 
CUS_ REV AAGCTTTTAGTTCACATGGCTCGTGG HindIII 
At4CL1_FW CATATGATGGCGCCACAAGAACA NdeI 
At4CL1_REV CTCGAGTCACAATCCATTTGCTAGTTTTGC XhoI 
CURS1_FW GGATCCTATGGCTAACCTGCACGCTC BamHI 
CURS1_REV GGCGCGCCTTACAGCGGCATAGAACGC AscI 
DCS_FW GGATCCGATGGAAGCTAACGGTTACCG BamHI 
DCS_REV AAGCTTTTAGTTCAGACGGCAAGAGTG HindIII 
TAL_FW CATATGGCTCCGCGTCC NdeI 
TAL_REV CTCGAGTTATGCCAGCATTTTCA XhoI 
CCoAOMT_FW 
CATATGCATCACCATCATCACCACATGGCTACGAATGAA
GACCAG NdeI 
CCoAOMT_REV CTCGAGTCATTTAATACGACGACAGATGGT XhoI 
[a] Start and stop codons in bold; restriction sites in italic; His6-Tag underlined; In order for the 
sequence to remain in frame one or two bases were occasionally added between the restriction site and 
the gene start codon. 
 2 
 3 
Figure S1. Protein gel showing DCS, CURS1 and CUS expression in cell-free extracts at 4 
time zero of induction and after 5 hours of induction. DCS and CURS1 have 42.90 kDa and 5 
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CUS has 44.33 kDa. DCS: diketide-CoA synthase; CURS1: curcumin synthase; CUS: 6 
curcuminoid synthase; M: Marker. 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
Figure S2. Curcuminoid production can be observed by the yellow / orange color of the 22 
cells. Bisdemethoxycurcumin (A, C) and curcumin (B, D) were produced using p-coumaric 23 
and ferulic acid as substrates, respectively. Two different combinations of enzymes were 24 
tested: CUS (A, B) and CURS1 and DCS (C, D). When curcuminoids are not produced the 25 
culture medium remains white (E). CUS: curcuminoid synthase; CURS1: curcumin 26 
synthase 1; DCS: diketide-CoA synthase. 27 
 28 
 29 
 30 
 31 
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Figure S3. Protein gel showing caffeoyl-CoA 3-O-methyltransferase (CCoAOMT) enzyme 33 
present in pRSFDuet-1 in cell-free extract. CCoAOMT is expected around 27.28 kDa. 34 
 35 
